My Watchlist Items

      No Watchlist
Array ( [0] => stdClass Object ( [symbol] => AEMD [price] => 6.49 [beta] => 0.563154 [volAvg] => 4987534 [mktCap] => 78732136 [lastDiv] => 0 [range] => 1.22-12.49 [changes] => -0.41 [companyName] => Aethlon Medical, Inc. [currency] => USD [cik] => 0000882291 [isin] => US00808Y3071 [cusip] => 00808Y307 [exchange] => Nasdaq Capital Market [exchangeShortName] => NASDAQ [industry] => Medical Devices [website] => http://www.aethlonmedical.com [description] => Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. The company is headquartered in San Diego, California and currently employs 6 full-time employees. The firm operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The firm's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer. [ceo] => Dr. Timothy Rodell [sector] => Healthcare [country] => US [fullTimeEmployees] => 8 [phone] => 18584597800 [address] => 9635 Granite Ridge Dr Ste 100 [city] => San Diego [state] => CALIFORNIA [zip] => 92123 [dcfDiff] => -1.02 [dcf] => 9.26134 [image] => https://financialmodelingprep.com/image-stock/AEMD.png [ipoDate] => 1994-03-09 [defaultImage] => [isEtf] => [isActivelyTrading] => 1 ) )
Aethlon Medical, Inc. (AEMD)
   6.49   -0.41(-5.94%)
Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. The company is headquartered in San Diego, California and currently employs 6 full-time employees. The firm operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The firm's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.
TitleNamePayCurrency PayGenderYear BornTitle Since
Consultant Dr. Richard H. Tullis N/A USD N/A N/A
Chief Medical Officer Mr. Steven P. Larosa N/A USD male N/A N/A
Head of Clinical Studies Mr. Sunil Sawhney N/A USD male N/A N/A
Senior Vice President, Chief Bus. Officer & Director Mr. Guy F. Cipriani BS (Eng.), MBA 34000 USD male 1971 N/A
Chief Financial Officer, Senior Vice President of Fin. & Sec. Mr. James B. Frakes 354750 USD male 1957 N/A
Chief Executive Officer, Director & Member of Extracorporeal Therapy Advisory Board Dr. Charles J. Fisher Jr. 124000 USD 1947 N/A
SymbolDateRatingRating Score Rating Details
AEMD 11 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 10 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 9 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 8 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 7 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 4 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 3 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 2 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 1 June, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 28 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 27 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 26 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 25 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 24 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 21 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 20 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 19 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 18 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 17 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 14 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 13 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 12 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 11 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 10 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 7 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 6 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 5 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 4 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 3 May, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 30 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 29 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 28 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 27 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 26 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 23 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 22 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 21 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 20 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 19 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 16 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 15 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 14 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 13 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 12 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 9 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 8 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 7 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 6 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 5 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 1 April, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 31 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 30 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 29 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 26 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 25 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 24 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 23 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 22 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 19 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 18 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 17 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 16 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 15 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 12 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 11 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 10 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 9 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 8 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 5 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 4 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 3 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 2 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 1 March, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 26 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 25 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 24 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 23 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 22 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 19 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 18 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 17 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 5 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 4 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 3 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 2 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 1 February, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 29 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 28 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 27 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 26 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 25 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 22 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 21 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 20 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 19 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 15 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 14 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 13 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 12 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
AEMD 11 January, 2021 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Sell)
Rating DCF: (Sell)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HolderSharesDate ReportedChange
CORDASCO FINANCIAL NETWORK 13598 31 March, 2021 0
GEODE CAPITAL MANAGEMENT, LLC 66753 31 December, 2020 49432
SCHONFELD STRATEGIC ADVISORS LLC 16500 31 December, 2020 16500
CARDAN CAPITAL PARTNERS, LLC 15896 31 December, 2020 15896
NORTHERN TRUST CORP 12134 31 December, 2020 -114
SIGMA PLANNING CORP 11375 31 December, 2020 -2444
BLACKROCK INC. 10253 31 December, 2020 0
ADVISOR GROUP HOLDINGS, INC. 6032 31 December, 2020 -22
UBS GROUP AG 3050 31 December, 2020 1401
WELLS FARGO & COMPANY/MN 2196 31 December, 2020 5
PNC FINANCIAL SERVICES GROUP, INC. 1454 31 December, 2020 0
MORGAN STANLEY 201 31 December, 2020 -66325
BANK OF AMERICA CORP /DE/ 84 31 December, 2020 84
VANGUARD GROUP INC 171182 31 December, 2020 48670
PRINCETON GLOBAL ASSET MANAGEMENT LLC 16 31 December, 2020 0
HolderSharesDate ReportedWeight Percent
Vanguard Extended Market Index Fund 122512 31 July, 2020 N/A
SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
AEMD 1 April, 2021 0001199102 43362 0000882291 JOHNSON SABRINA MARTUCCI A 4 24295 Common Stock View
AEMD 1 April, 2021 0001284599 45106 0000882291 BROENNIMAN EDWARD G A 4 24295 Common Stock View
AEMD 1 April, 2021 0001566040 35786 0000882291 Shah Chetan A 4 24295 Common Stock View
AEMD 31 March, 2021 0001199102 19067 0000882291 JOHNSON SABRINA MARTUCCI D 4 2575 Common Stock View
AEMD 31 March, 2021 0001284599 20811 0000882291 BROENNIMAN EDWARD G D 4 2575 Common Stock View
AEMD 31 March, 2021 0001566040 11491 0000882291 Shah Chetan D 4 2575 Common Stock View
AEMD 31 March, 2021 0001408469 19569 0000882291 FISHER CHARLES J JR D 4 2575 Common Stock View
AEMD 31 March, 2021 0001745825 17901 0000882291 Cipriani Guy F. D 4 2575 Common Stock View
AEMD 4 January, 2021 0001745825 120883 0000882291 Cipriani Guy F. A 4 120883 Employee Stock Option (Right to Buy) View
AEMD 4 January, 2021 0001839524 120883 0000882291 LAROSA STEVEN P A 4 120883 Employee Stock Option (Right to Buy) View
AEMD 31 December, 2020 0001566040 14066 0000882291 Shah Chetan D 4 2575 Common Stock View
AEMD 31 December, 2020 0001199102 21642 0000882291 JOHNSON SABRINA MARTUCCI D 4 2575 Common Stock View
AEMD 31 December, 2020 0001284599 23386 0000882291 BROENNIMAN EDWARD G D 4 2575 Common Stock View
AEMD 31 December, 2020 0001745825 20476 0000882291 Cipriani Guy F. D 4 2575 Common Stock View
AEMD 31 December, 2020 0001408469 22144 0000882291 FISHER CHARLES J JR D 4 2575 Common Stock View
AEMD 17 December, 2020 0001566040 22392 0000882291 Shah Chetan D 4 21101 Common Stock View
AEMD 17 December, 2020 0001566040 16975 0000882291 Shah Chetan D 4 5417 Common Stock View
AEMD 17 December, 2020 0001566040 16641 0000882291 Shah Chetan D 4 334 Common Stock View
AEMD 30 October, 2020 0001408469 239122 0000882291 FISHER CHARLES J JR A 4 239122 Employee Stock Option (Right to Buy) View
AEMD 30 September, 2020 0001745825 23051 0000882291 Cipriani Guy F. D 4 2389 Common Stock View
AEMD 30 September, 2020 0001284599 25961 0000882291 BROENNIMAN EDWARD G D 4 2389 Common Stock View
AEMD 30 September, 2020 0001566040 43493 0000882291 Shah Chetan D 4 2389 Common Stock View
AEMD 30 September, 2020 0001408469 24719 0000882291 FISHER CHARLES J JR D 4 2389 Common Stock View
AEMD 30 September, 2020 0001199102 24217 0000882291 JOHNSON SABRINA MARTUCCI D 4 2389 Common Stock View
AEMD 30 June, 2020 0001284599 27421 0000882291 BROENNIMAN EDWARD G D 4 2389 Common Stock View
AEMD 30 June, 2020 0001408469 26179 0000882291 FISHER CHARLES J JR D 4 2389 Common Stock View
AEMD 30 June, 2020 0001745825 24511 0000882291 Cipriani Guy F. D 4 2389 Common Stock View
AEMD 30 June, 2020 0001566040 44953 0000882291 Shah Chetan D 4 2389 Common Stock View
AEMD 30 June, 2020 0001199102 25677 0000882291 JOHNSON SABRINA MARTUCCI D 4 2389 Common Stock View
AEMD 3 April, 2020 0001284599 29810 0000882291 BROENNIMAN EDWARD G A 4 23893 Common Stock View
AEMD 3 April, 2020 0001745825 26900 0000882291 Cipriani Guy F. A 4 23893 Common Stock View
AEMD 3 April, 2020 0001566040 47342 0000882291 Shah Chetan A 4 23893 Common Stock View
AEMD 3 April, 2020 0001199102 28066 0000882291 JOHNSON SABRINA MARTUCCI A 4 23893 Common Stock View
AEMD 3 April, 2020 0001408469 28568 0000882291 FISHER CHARLES J JR A 4 23893 Common Stock View
AEMD 3 April, 2020 0001284599 28350 0000882291 BROENNIMAN EDWARD G A 4 929 Common Stock View
AEMD 3 April, 2020 0001408469 27108 0000882291 FISHER CHARLES J JR A 4 929 Common Stock View
AEMD 3 April, 2020 0001745825 25440 0000882291 Cipriani Guy F. A 4 929 Common Stock View
AEMD 3 April, 2020 0001199102 26606 0000882291 JOHNSON SABRINA MARTUCCI A 4 929 Common Stock View
AEMD 3 April, 2020 0001185553 140472 0000882291 FRAKES JAMES B A 4 140472 Employee Stock Option (right to buy) View
AEMD 3 April, 2020 0001260316 202280 0000882291 RODELL TIMOTHY C JR A 4 202280 Employee Stock Option (right to buy) View
AEMD 3 April, 2020 0001566040 45882 0000882291 Shah Chetan A 4 929 Common Stock View
AEMD 31 March, 2020 0001199102 4173 0000882291 JOHNSON SABRINA MARTUCCI D 4 244 Common Stock View
AEMD 31 March, 2020 0001566040 23449 0000882291 Shah Chetan D 4 244 Common Stock View
AEMD 31 March, 2020 0001408469 4675 0000882291 FISHER CHARLES J JR D 4 244 Common Stock View
AEMD 31 March, 2020 0001745825 3007 0000882291 Cipriani Guy F. D 4 244 Common Stock View
AEMD 31 January, 2020 0001185553 2483 0000882291 FRAKES JAMES B D 4 125 Common Stock View
AEMD 31 December, 2019 0001566040 23693 0000882291 Shah Chetan D 4 246 Common Stock View
AEMD 31 December, 2019 0001199102 4417 0000882291 JOHNSON SABRINA MARTUCCI D 4 246 Common Stock View
AEMD 31 December, 2019 0001745825 3251 0000882291 Cipriani Guy F. D 4 246 Common Stock View
AEMD 31 December, 2019 0001408469 4919 0000882291 FISHER CHARLES J JR D 4 246 Common Stock View
AEMD 30 October, 2019 0001185553 2608 0000882291 FRAKES JAMES B D 4 115 Common Stock View
AEMD 30 September, 2019 0001408469 77469 0000882291 FISHER CHARLES J JR D 4 3684 Common Stock View
AEMD 30 September, 2019 0001566040 359075 0000882291 Shah Chetan D 4 3684 Common Stock View
AEMD 30 September, 2019 0001199102 69944 0000882291 JOHNSON SABRINA MARTUCCI D 4 3684 Common Stock View
AEMD 30 September, 2019 0001745825 52444 0000882291 Cipriani Guy F. D 4 3684 Common Stock View
AEMD 31 July, 2019 0001185553 2723 0000882291 FRAKES JAMES B D 4 113 Common Stock View
AEMD 30 June, 2019 0001566040 362759 0000882291 Shah Chetan D 4 3684 Common Stock View
AEMD 30 June, 2019 0001408469 81153 0000882291 FISHER CHARLES J JR D 4 3684 Common Stock View
AEMD 30 June, 2019 0001199102 73628 0000882291 JOHNSON SABRINA MARTUCCI D 4 3684 Common Stock View
AEMD 30 June, 2019 0001745825 56128 0000882291 Cipriani Guy F. D 4 3684 Common Stock View
AEMD 30 April, 2019 0001185553 2836 0000882291 FRAKES JAMES B D 4 129 Common Stock View
AEMD 1 April, 2019 0001408469 36842 0000882291 FISHER CHARLES J JR A 4 36842 Restricted Stock Units (RSU) View
AEMD 1 April, 2019 0001566040 36842 0000882291 Shah Chetan A 4 36842 Restricted Stock Units (RSU) View
AEMD 1 April, 2019 0001284599 36842 0000882291 BROENNIMAN EDWARD G A 4 36842 Restricted Stock Units (RSU) View
AEMD 1 April, 2019 0001199102 36842 0000882291 JOHNSON SABRINA MARTUCCI A 4 36842 Restricted Stock Units (RSU) View
AEMD 1 April, 2019 0001745825 36842 0000882291 Cipriani Guy F. A 4 36842 Restricted Stock Units (RSU) View
AEMD 1 April, 2019 0001284599 88747 0000882291 BROENNIMAN EDWARD G A 4/A 36842 Common Stock View
AEMD 31 March, 2019 0001199102 40470 0000882291 JOHNSON SABRINA MARTUCCI D 5 3573 Common Stock View
AEMD 31 March, 2019 0001566040 329601 0000882291 Shah Chetan D 5 3573 Common Stock View
AEMD 31 March, 2019 0001408469 47995 0000882291 FISHER CHARLES J JR D 5 3573 Common Stock View
AEMD 31 March, 2019 0001745825 22970 0000882291 Cipriani Guy F. D 5 5105 Common Stock View
AEMD 29 March, 2019 0001185553 44470 0000882291 FRAKES JAMES B D 5 4529 Common Stock View
AEMD 18 January, 2019 0001185553 48999 0000882291 FRAKES JAMES B D 5 1922 Common Stock View
AEMD 31 December, 2018 0001199102 44043 0000882291 JOHNSON SABRINA MARTUCCI D 5 3573 Common Stock View
AEMD 31 December, 2018 0001566040 333174 0000882291 Shah Chetan D 5 3573 Common Stock View
AEMD 31 December, 2018 0001408469 51568 0000882291 FISHER CHARLES J JR D 5 3573 Common Stock View
AEMD 31 December, 2018 0001745825 28075 0000882291 Cipriani Guy F. D 5 5105 Common Stock View
AEMD 19 December, 2018 0001185553 50921 0000882291 FRAKES JAMES B D 5 4047 Common Stock View
AEMD 10 December, 2018 0001260316 552625 0000882291 RODELL TIMOTHY C JR A 4 552625 Employee Stock Option (Right to Buy) View
AEMD 31 October, 2018 0001033519 22435 0000882291 KENLEY RODNEY S D 4 3250 Restricted Stock Units View
AEMD 31 October, 2018 0001185553 46539 0000882291 FRAKES JAMES B D 4 3250 Restricted Stock Units View
AEMD 31 October, 2018 0001318931 279064 0000882291 Joyce James A D 4 39625 Restricted Stock Units View
AEMD 31 October, 2018 0001033519 20358 0000882291 KENLEY RODNEY S A 4 1768 Common Stock View
AEMD 31 October, 2018 0001318931 212370 0000882291 Joyce James A A 4 18683 Common Stock View
AEMD 31 October, 2018 0001185553 17877 0000882291 FRAKES JAMES B A 4 1532 Common Stock View
AEMD 30 October, 2018 0001185553 54968 0000882291 FRAKES JAMES B D 5 1718 Common Stock View
AEMD 30 September, 2018 0001408469 55141 0000882291 FISHER CHARLES J JR D 5 3573 Common Stock View
AEMD 30 September, 2018 0001199102 47616 0000882291 JOHNSON SABRINA MARTUCCI D 5 3573 Common Stock View
AEMD 30 September, 2018 0001566040 336747 0000882291 Shah Chetan D 5 3573 Common Stock View
AEMD 30 September, 2018 0001745825 33180 0000882291 Cipriani Guy F. D 5 5105 Common Stock View
AEMD 28 September, 2018 0001185553 56686 0000882291 FRAKES JAMES B D 4/A 4015 Common Stock View
AEMD 31 July, 2018 0001185553 49789 0000882291 FRAKES JAMES B D 4 3250 Restricted Stock Units View
AEMD 31 July, 2018 0001185553 60701 0000882291 FRAKES JAMES B D 4/A 1688 Common Stock View
AEMD 31 July, 2018 0001033519 25685 0000882291 KENLEY RODNEY S D 4 3250 Restricted Stock Units View
AEMD 31 July, 2018 0001318931 318689 0000882291 Joyce James A D 4 39625 Restricted Stock Units View
AEMD 31 July, 2018 0001185553 16345 0000882291 FRAKES JAMES B A 4 1562 Common Stock View
AEMD 31 July, 2018 0001033519 18590 0000882291 KENLEY RODNEY S A 4 1797 Common Stock View
AEMD 31 July, 2018 0001318931 193687 0000882291 Joyce James A A 4 18683 Common Stock View
AEMD 19 June, 2018 0001185553 53039 0000882291 FRAKES JAMES B A 4 22971 Restricted Stock Units View
AEMD 19 June, 2018 0001408469 79990 0000882291 FISHER CHARLES J JR A 4 26799 Restricted Stock Units View

Charts

Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated
23 June, 2021 AEMD bmo 0 370000
10 February, 2021 AEMD -0.2 -0.2 amc 624871 100000
28 October, 2020 AEMD -0.15 -0.15 amc 0 0
11 August, 2020 AEMD amc 0 0
25 June, 2020 AEMD -0.22 -0.22 bmo 206730 150349.09090909
10 February, 2020 AEMD -0.28 -0.28 amc 413460 1520942.1428571
1 November, 2019 AEMD -1.29 -1.29 amc 30000 25581.395348837
14 August, 2019 AEMD -1.65 -1.65 amc 30000 21818.181818182
1 July, 2019 AEMD -1.35 -1.35 amc 30000 23333.333333333
11 February, 2019 AEMD -1.65 -1.65 amc 149625 95215.909090909
6 November, 2018 AEMD -1.2 -1.2 amc 149625 130921.875
8 August, 2018 AEMD -0.9 -0.9 amc 150000 200000
8 June, 2018 AEMD -0.9 -0.9 amc 70000 116666.66666667
1 February, 2018 AEMD -1.2 -1.2 amc 70000 96250
2 November, 2017 AEMD amc 0 0
10 August, 2017 AEMD amc 0 0
28 June, 2017 AEMD amc 392073 0
10 February, 2017 AEMD amc 392073 0
10 November, 2016 AEMD amc 390000 0
11 August, 2016 AEMD amc 4635 0
29 June, 2016 AEMD amc 200000 0
4 February, 2016 AEMD amc 300000 0
16 November, 2015 AEMD amc 190000 0
13 August, 2015 AEMD amc 190000 0
26 June, 2015 AEMD bmo 200000 0
10 February, 2015 AEMD -0.5 -0.5 bmo 30000 0
10 November, 2014 AEMD bmo 480000 0
14 August, 2009 AEMD -15 -15 bmo 0 0
2 July, 2009 AEMD -15 -15 bmo 0 0
17 February, 2009 AEMD -37.5 -37.5 bmo 0 0

Company Profile

Company Name Aethlon Medical, Inc.
Symbol AEMD
Currency USD
Price 6.49
Exchange Name Nasdaq Capital Market (NASDAQ)
Industry Medical Devices
CEO Dr. Timothy Rodell
Sector Healthcare
Country US
Full Time Employees 8
Phone 18584597800
Address 9635 Granite Ridge Dr Ste 100
City San Diego
State CALIFORNIA
Zip 92123
>